BluDiagnostics Inc., a Madison health technology startup and maker of a device that helps women struggling with infertility, has raised $3.4 million in debt funding from two investors, according to a recent filing with the U.S. Securities and Exchange Commission.
The company’s Fertility Finder device analyzes salivary hormones and displays the information on an app, which can also be transmitted to a woman’s physician.
BluDiagnostics previously raised $1.15 million in an amended round of debt funding in 2016, according to SEC documents.
BluDiagnostics CEO Katie Brenner co-founded the company in 2015 while completing her postdoctoral fellowship in biochemistry at the University of Wisconsin-Madison. The startup won the top prize in the Governor’s Business Plan Contest at the annual Wisconsin Entrepreneurs’ Conference in 2015. It also won the life sciences category that year. Read the full story here.